To Evaluate the Long-term Efficacy and Safety of Toludevenlafaxine Hydrochloride Sustained-release Tablets
Clinical trial NCT06426485 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06426485
- Sponsor
- Luye Pharma Group Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-30
- Primary completion
- 2027-02-28
- Enrollment
- 736
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.